GNTA — Genenta Science SpA Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Genenta Science SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 37.2 | 29.8 | 18.8 | 12.7 | 28.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.48 | 1.6 | 2.04 | 1.48 | 1.3 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 38.8 | 31.7 | 21.3 | 14.5 | 30 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.023 | 0.112 | 0.083 | 0.043 | 0.022 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 40 | 33.4 | 22.3 | 14.8 | 31.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.14 | 2.18 | 1.74 | 2.1 | 2.12 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.17 | 2.3 | 1.91 | 2.33 | 10 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 38.9 | 31.1 | 20.4 | 12.5 | 21.8 |
| Total Liabilities & Shareholders' Equity | 40 | 33.4 | 22.3 | 14.8 | 31.9 |
| Total Common Shares Outstanding |